ALEXANDRA SAMADI: Open Payments
NPI 1992401079 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 43 payments from 11 companies in 2025. Trend: 2023 $500 · 2024 $825 · 2025 $1,480
Food & beverage: $1,435Education: $44
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $459 |
| GENZYME CORPORATION | 8 | $380 |
| Bausch & Lomb Americas Inc. | 5 | $186 |
| Optinose US, Inc. | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Mallinckrodt Hospital Products Inc. | 2 | $59 |
| Alcon Vision LLC | 2 | $49 |
| OPKO Pharmaceuticals, LLC | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 1 | $30 |
Products named: DUPIXENT, NUCALA, Xhance, VYZULTA, ACTHAR, XIIDRA, Rocklatan, RAYALDEE.
Industry payments across NY — which companies pay providers there.
